Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mather

Showing results (61-70 of 504) with videos related to

Pageof 51
Sort By:
The Gerontologist|January 1, 1971
Color preferences in a geriatric populationJ Mather, C Stare, S Breinin
Annals of Surgery|May 1, 1988
Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional diseaseC M Sutherland, F J Mather
Endocrinology|December 1, 1992
In vitro ligand binding of 125I-recombinant human activin A to the female rat brainL Jakeman, J Mather, T Woodruff
Journal of Surgical Oncology|September 1, 1992
Prophylactic lymph node dissection for malignant melanoma: what to do while we waitC M Sutherland, F J Mather
Heart Failure Reviews|June 2, 2007
Newer mechanical devices in the management of acute heart failurePaul J Mather, Marvin A Konstam
Journal of Diabetes and Its Complications|November 21, 2012
Measuring the transition to diabetesTamara S Hannon, Kieren J Mather
Best Practice & Research. Clinical Endocrinology & Metabolism|January 15, 2014
Clinical use of adiponectin as a marker of metabolic dysregulationKieren J Mather, Ronald B Goldberg
Therapeutic Advances in Cardiovascular Disease|March 29, 2021
The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fractionMichael V Genuardi, Paul J Mather
Cancer|March 15, 1985
Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment)C M Sutherland, F J Mather
Cancer Letters|June 1, 1989
Hematologic effects of short-term oral diethylcarbamazine treatment given to chronically feline leukemia virus-infected catsL W Kitchen, F J Mather
Pageof 51

Showing results (61-70 of 504) with videos related to

Sort By:
Pageof 51
The Gerontologist|January 1, 1971
Color preferences in a geriatric populationJ Mather, C Stare, S Breinin
Annals of Surgery|May 1, 1988
Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional diseaseC M Sutherland, F J Mather
Endocrinology|December 1, 1992
In vitro ligand binding of 125I-recombinant human activin A to the female rat brainL Jakeman, J Mather, T Woodruff
Journal of Surgical Oncology|September 1, 1992
Prophylactic lymph node dissection for malignant melanoma: what to do while we waitC M Sutherland, F J Mather
Heart Failure Reviews|June 2, 2007
Newer mechanical devices in the management of acute heart failurePaul J Mather, Marvin A Konstam
Journal of Diabetes and Its Complications|November 21, 2012
Measuring the transition to diabetesTamara S Hannon, Kieren J Mather
Best Practice & Research. Clinical Endocrinology & Metabolism|January 15, 2014
Clinical use of adiponectin as a marker of metabolic dysregulationKieren J Mather, Ronald B Goldberg
Therapeutic Advances in Cardiovascular Disease|March 29, 2021
The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fractionMichael V Genuardi, Paul J Mather
Cancer|March 15, 1985
Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment)C M Sutherland, F J Mather
Cancer Letters|June 1, 1989
Hematologic effects of short-term oral diethylcarbamazine treatment given to chronically feline leukemia virus-infected catsL W Kitchen, F J Mather
Pageof 51